Global Chemiluminescence Immunoassays (CLIA) Market Research Report
- Report Code: CH 1000
- Publish Date: Upcoming
At present, Chemiluminescence immunoassays (CLIA) offer one of the best solutions for the quantification of low concentrations of samples from a complex mixture. The non-radioactive nature of the technique enables it to replace RIA in several immunoassay applications in varied disciplines, including microbiology, agriculture, clinical laboratory, therapeutic medicine, and so on.
Geographically, CLIA has a broad market in developed economies of the world like U.S. and Europe as it is a fully automated system that offers highly accurate results.
The report “Global Chemiluminescence immunoassays (CLIA) Market” analyzes the market by three segments such as instruments, reagents and applications.
The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the Americas Chemiluminescence immunoassays (CLIA) market, Germany commanded the largest share of the European Chemiluminescence immunoassays (CLIA) market, Japan commanded the largest share of the Asia-Pacific Chemiluminescence immunoassays (CLIA) market.
The report also provides an extensive competitive landscaping of companies operating in this market. The major vendors in this market are Ortho Clinical Diagnostics, Inc. (U.S.), Siemens Healthcare Diagnostics (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Beckman Coulter, Inc. (U.S.), and bioMérieux (France).
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
Customization Options:
Along with the market data, you can also customize MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standards and deep dive analysis of the following parameters:
Opportunity Analysis
- Unmet needs, revenue pockets and potential areas for expansion
- Comprehensive review of key component providers, assay providers, sole service providers, complete solution providers
Current and Emerging Products
- Analysis of current and emerging Chemiluminescence immunoassays (CLIA) (FIA)and immunodiagnostic tests
- Review of current instrumentation technologies
Pricing Trends
- Pricing trend of new high value Immunoassay tests
Product Analysis
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user Adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virility and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
Alternative Products: Impact analysis
MMM’s Healthcare Decision Making Quadrant It is an innovative and useful quadrant for vendors who wish to analyze the potential growth markets based on parameters like Patient dynamics (Patient pool, epidemiology of disease, preference towards surgeries/alternative therapies) and Macroeconomic indicators (Number of Hospitals and Orthopedic clinics, reimbursement scenario, diagnosis rate, treatment rate and healthcare expenditure)
1 Introduction
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Applications
4.1 Cancer
4.2 Endocrine disorders
4.3 Cardiovascular Disorders
4.4 Infectious disease
4.5 Auto-immune Diseases
4.6 Blood Disorders
4.7 Bone and Mineral Disorders
4.8 Toxicology Screening
5 By Endusers
5.1 Hospitals
5.2 Medical & Diagnostic Laboratories
5.3 Pharmaceuticals
5.4 Contract Research Organization (CRO)
6 By Types
6.1 Medium Throughput
6.2 Low Throughput
6.3 High Throughput
7 By Geographies
7.1 Americas
7.2 Europe
7.3 Asia-Pacific
7.4 Rest of World
8 By Companies
8.1 Siemens AG Healthcare
8.2 Johnson & Johnson
8.3 BioMérieux
8.4 Abbott Laboratories
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
Asia Chemiluminescence Immunoassays (CLIA) Japan commanded the largest share of the Asia-Pacific Chemiluminescence immunoassays (CLIA) market. The report “Asian Chemiluminescence immunoassays (CLIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. The report also provides an extensive competitive landscaping of companies operating in this market. |
Upcoming |
|
|
North America Chemiluminescence Immunoassays (CLIA) The Americas is estimated to be the largest market for enzyme immunoassays, followed by Europe. The U.S. commanded the largest share of the North American Chemiluminescence immunoassays (CLIA) market. The report “North American Chemiluminescence immunoassays (CLIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. |
Upcoming |
|
|
Europe Chemiluminescence Immunoassays (CLIA) The report “European Chemiluminescence immunoassays (CLIA) Market forecast for 2018 “analyzes the market by three segments such as instruments, reagents and applications. Germany commanded the largest share of the European Chemiluminescence immunoassays (CLIA) market. The report also provides an extensive competitive landscaping of companies operating in this market. The major vendors in this market are Ortho Clinical Diagnostics, Inc. (U.S.), Siemens Healthcare Diagnostics (Germany), Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Beckman Coulter, Inc. (U.S.), and bioMérieux (France). |
Upcoming |
